Skip to main content

HARVARD BIOSCIENCE INC (HBIO) Stock Forecast 2025 - AI Price Prediction & Analysis


HARVARD BIOSCIENCE INC (HBIO) AI Stock Price Forecast & Investment Analysis

HARVARD BIOSCIENCE INC Stock Price Chart and Technical Analysis

Loading HARVARD BIOSCIENCE INC interactive price chart and technical analysis...

HARVARD BIOSCIENCE INC (HBIO) - Comprehensive Stock Analysis & Investment Research

Deep dive into HARVARD BIOSCIENCE INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about HARVARD BIOSCIENCE INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For HARVARD BIOSCIENCE INC: HARVARD BIOSCIENCE INC operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

HARVARD BIOSCIENCE INC (Stock Symbol: HBIO) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry.

The organization employs approximately 168 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing HARVARD BIOSCIENCE INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For HARVARD BIOSCIENCE INC: With $88M in annual revenue and -59.9% net margin, the company demonstrates developing profitability.

Annual Revenue: $88 million generating a -59.9% net profit margin .

Market Capitalization: $21 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -8.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for HARVARD BIOSCIENCE INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For HARVARD BIOSCIENCE INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for HARVARD BIOSCIENCE INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: HARVARD BIOSCIENCE INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For HARVARD BIOSCIENCE INC: Market positioning analysis based on available financial and operational metrics.

HARVARD BIOSCIENCE INC strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 240.1% gross margin, indicating strong pricing power and operational efficiency.

HARVARD BIOSCIENCE INC (HBIO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for HARVARD BIOSCIENCE INC stock analysis.

Loading HARVARD BIOSCIENCE INC comprehensive fundamental analysis and insider trading data...

Deep dive into HARVARD BIOSCIENCE INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if HARVARD BIOSCIENCE INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For HARVARD BIOSCIENCE INC: With a P/E ratio of -8.33, the market sees the stock as potentially undervalued.

P/E Ratio -8.33x
P/B Ratio 1.36x
Market Cap $21M
EPS $-1.29
Book Value/Share $0.35
Revenue/Share $1.99
FCF/Share $0.20
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently HARVARD BIOSCIENCE INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For HARVARD BIOSCIENCE INC: An ROE of -8.5% indicates room for improvement in shareholder value creation.

ROE -8.5%
ROA -4.2%
ROIC -4.2%
Gross Margin 240.1%
Operating Margin -25.0%
Net Margin -59.9%
EBT Margin -5.4%
Tax Rate 46.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess HARVARD BIOSCIENCE INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For HARVARD BIOSCIENCE INC: A current ratio of 2.18 indicates strong liquidity.

Current Ratio 2.18x
Quick Ratio 0.94x
D/E Ratio 0.69x
Financial Leverage 2.07x
Interest Coverage -3.3x
Working Capital $31M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal HARVARD BIOSCIENCE INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For HARVARD BIOSCIENCE INC: Free cash flow of $-3M indicates cash challenges that need attention.

Operating Cash Flow $-2M
Free Cash Flow $-3M
Capital Spending $-2M
OCF Growth YoY 16.0%
FCF Growth YoY 19.8%
FCF/Sales -2.7%
CapEx/Sales 1.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively HARVARD BIOSCIENCE INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For HARVARD BIOSCIENCE INC: An asset turnover of 0.78x suggests room for improvement in asset utilization.

Asset Turnover 0.78x
Receivables Turnover 6.5x
Inventory Turnover 2.0x
Fixed Assets Turnover 11.4x
Days Sales Outstanding 56 days
Days Inventory 179 days
Payables Period 44 days
Cash Conversion Cycle 192 days
Understanding Financial Statement Data

What these metrics mean: Key figures from HARVARD BIOSCIENCE INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For HARVARD BIOSCIENCE INC: With annual revenue of $88M, HARVARD BIOSCIENCE INC represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $88M
R&D Expense $11M
SG&A Expense $42M
Cost of Goods Sold $41M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 38%
Cash & Short-term Investments 3%
Total Liabilities 52%
Short-term Debt 2%
Accounts Receivable 13%
Inventory 18%
Dividend & Shareholder Information
Shares Outstanding 45M
Growth Metrics (YoY)
EPS Growth -10.8%

Latest HARVARD BIOSCIENCE INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting HARVARD BIOSCIENCE INC (HBIO) stock price and investment outlook.

📰 We are currently updating our news feed for HARVARD BIOSCIENCE INC. Check back soon for the latest market analysis and company updates.

HARVARD BIOSCIENCE INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of HARVARD BIOSCIENCE INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast - 30 Days FREE Trial $35981M 29.5x 5.7x
AKYA Unlock Forecast - 30 Days FREE Trial $64M -2.1x -10.9x
ASTC Unlock Forecast - 30 Days FREE Trial $8M 28.9x 0.3x
AVTR Unlock Forecast - 30 Days FREE Trial $8750M 12.7x 1.4x
AXDX Unlock Forecast - 30 Days FREE Trial $0M -0.2x 0.0x
BIO Unlock Forecast - 30 Days FREE Trial $7889M 24.7x 1.1x
BIO-B Unlock Forecast - 30 Days FREE Trial $6816M 21.4x 1.0x
BNGO Unlock Forecast - 30 Days FREE Trial $16M 0.0x 0.3x
BRKR Unlock Forecast - 30 Days FREE Trial $6145M 28.3x 3.2x
CTKB Unlock Forecast - 30 Days FREE Trial $523M 82.0x 1.4x
EYPT Unlock Forecast - 30 Days FREE Trial $965M -4.4x 3.9x
HBIO Unlock Forecast - 30 Days FREE Trial $21M -8.3x 1.4x
ILMN Unlock Forecast - 30 Days FREE Trial $15519M 12.4x 6.9x
LAB Unlock Forecast - 30 Days FREE Trial $519M -2.4x 1.2x
LCTC Unlock Forecast - 30 Days FREE Trial $9M x 1.5x
MTD Unlock Forecast - 30 Days FREE Trial $24913M 31.5x -136.9x
NAUT Unlock Forecast - 30 Days FREE Trial $83M -3.8x 0.5x
OMIC Unlock Forecast - 30 Days FREE Trial $50M -1.7x 0.4x
PACB Unlock Forecast - 30 Days FREE Trial $381M -1.5x 6.2x
PRPO Unlock Forecast - 30 Days FREE Trial $22M -1.2x 0.6x
QTRX Unlock Forecast - 30 Days FREE Trial $209M -11.1x 0.7x
RPID Unlock Forecast - 30 Days FREE Trial $121M -0.9x 2.2x
RVTY Unlock Forecast - 30 Days FREE Trial $10110M 35.5x 1.3x
SEER Unlock Forecast - 30 Days FREE Trial $129M -2.0x 0.4x
TXG Unlock Forecast - 30 Days FREE Trial $1675M -8.6x 2.2x
WAT Unlock Forecast - 30 Days FREE Trial $17937M 27.1x 8.3x

Frequently Asked Questions - HARVARD BIOSCIENCE INC Stock Forecast

How accurate are HARVARD BIOSCIENCE INC stock predictions?

Our AI model demonstrates 65% historical accuracy for HBIO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence HARVARD BIOSCIENCE INC stock price forecasts?

Our analysis considers HARVARD BIOSCIENCE INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is HARVARD BIOSCIENCE INC a good investment in 2025?

Based on our AI analysis, HARVARD BIOSCIENCE INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are HARVARD BIOSCIENCE INC forecasts updated?

HARVARD BIOSCIENCE INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced HARVARD BIOSCIENCE INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for HARVARD BIOSCIENCE INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...